Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKR) Cost of Revenue (2016 - 2025)

Bruker (BRKR) has disclosed Cost of Revenue for 16 consecutive years, with $528.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 8.57% year-over-year to $528.0 million, compared with a TTM value of $1.9 billion through Dec 2025, up 8.26%, and an annual FY2025 reading of $1.9 billion, up 8.26% over the prior year.
  • Cost of Revenue was $528.0 million for Q4 2025 at Bruker, up from $481.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $528.0 million in Q4 2025 and bottomed at $276.0 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $373.0 million, with a median of $351.2 million recorded in 2022.
  • The sharpest move saw Cost of Revenue changed 0.0% in 2022, then grew 23.85% in 2023.
  • Year by year, Cost of Revenue stood at $341.9 million in 2021, then rose by 0.18% to $342.5 million in 2022, then increased by 23.85% to $424.2 million in 2023, then grew by 14.64% to $486.3 million in 2024, then increased by 8.57% to $528.0 million in 2025.
  • Business Quant data shows Cost of Revenue for BRKR at $528.0 million in Q4 2025, $481.1 million in Q3 2025, and $439.5 million in Q2 2025.